X4 Pharmaceuticals, Inc — Director's Dealing 2019

Apr 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2019-03-29

Reporting Person: Stewart Murray (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-29	Stock Option (right to buy)	$17.41	A	6854	Acquired	2029-03-29	Common Stock (6854)	Direct

Footnotes

F1: 33.3333% of the shares subject to the option shall vest on March 29, 2020, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the award, subject the Reporting Person continuing to provide services through each such date. This option was granted automatically upon the Reporting Person's election to the Board of Directors of the Issuer.